TP53 and cancer: The number of cancer types with significantly upregulated MKI67 expression levels in the TP53 mutant group in comparison to the TP53 wild-type group was 12/17 (70.6%) in cluster A1 and 1/4 (25.0%) in cluster A2 (P = 0.2528, Table 3).